Effect of Fibroblast Growth Factor-21 Molecule on Coronary Collateral Development

被引:0
|
作者
Fedai, Halil [1 ]
Tascanov, Mustafa Begenc [2 ]
机构
[1] Sanliurfa Training & Res Hosp, Clin Cardiol, Sanliurfa, Turkiye
[2] Harran Univ, Fac Med, Dept Cardiol, Sanliurfa, Turkiye
关键词
Fibroblast growth factor-21; coronary collateral; coronary artery disease; angiogenesis; coronary angiography; pathophysiology; ARTERY OCCLUSION; CIRCULATION;
D O I
10.2174/1386207326666221026151525
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Collateral arteries provide an alternative source to the myocardium resulting from ischemia due to occlusive coronary artery disease and may help preserve myocardial function in the case of coronary artery disease (CAD). Although collateral development is so important, its pathophysiology has not been fully elucidated. Till now, no study has investigated the relationship between Fibroblast growth factor-21(FGF-21) and coronary collateral. Objective: This study aims to investigate the pathophysiology of coronary collateral development. Methods: In our study, which we planned as a case-control, 60 consecutive patients with >= 90 stenosis in at least one large coronary artery as a result of coronary angiography (CAG) and 30 patients with normal coronary angiography were included in the study cross-sectional. Demographic, echocardiographic and laboratory data were recorded. Coronary collateral circulation was evaluated using the Rentrop-Cohen method. FGF-21 levels were measured in all individuals. Results: In the analysis, no significant difference was observed between the two groups in basic biochemical parameters other than HDL (p>0.05 for all). FGF-21 level was statistically significantly higher in the patient group compared to the control group (p: 0.003). Also, the FGF-21 level was found to be statistically significantly higher in the good collateral circulation group than the poor (p:0.006). Univariate and multivariate logistic regression analysis was performed to predict the presence of collateral. We found that FGF-21(p=0.006), and C-reactive protein (p=0.020) predicted the presence of collateral independently. Conclusion: Collateral formation and cardiac prognosis are closely related. Our study is the first to investigate the relationship between collateral formation and FGF-21. Our study showed that the FGF-21 level is an independent predictor of collateral formation. In addition, there was a significant difference between bad and good collateral formation regarding FGF-21 levels.
引用
收藏
页码:2090 / 2095
页数:6
相关论文
共 50 条
  • [1] Role of fibroblast growth factor-21 in alcoholic cardiomyopathy
    Ferrer-Curriu, G.
    Guitart-Mampel, M.
    Garrabou, G.
    Villarroya, F.
    Fernandez-Sola, J.
    Planavila, A.
    CARDIOVASCULAR RESEARCH, 2018, 114 : S31 - S31
  • [2] Fibroblast Growth Factor-21 in clinical islet transplantation
    Meier, Raphael
    Niclauss, Nadja
    Morel, Philippe
    Demuylder-Mischler, Sandrine
    Asrih, Mohamed
    Bosco, Domenico
    Jornayvaz, Francois
    Berney, Thierry
    TRANSPLANTATION, 2016, 100 (07) : S407 - S407
  • [3] Fibroblast growth factor-21: A link for glucose homeostasis
    Naderali, Ebrahim K.
    Wong, Christopher
    Hussain, Munir
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2009, 3 (04) : 237 - 239
  • [4] Fibroblast growth factor-21, energy balance and obesity
    Giralt, Marta
    Gavalda-Navarro, Aleix
    Villarroya, Francesc
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 418 : 66 - 73
  • [5] Acromegaly is associated with high fibroblast growth factor-21 levels
    B. S. Yurekli
    N. O. Kutbay
    M. Aksit
    A. Suner
    I. Y. Simsir
    S. Seckiner
    G. U. Kocabas
    G. Bozkaya
    F. Saygili
    Journal of Endocrinological Investigation, 2019, 42 : 53 - 60
  • [6] Fibroblast growth factor-21 attenuates olanzapine induced hyperglycemia
    Jeromson, Stewart
    Medak, Kyle
    Bellucci, Annalaura
    Arbeau, Meagan
    Wright, David
    PHYSIOLOGY, 2023, 38
  • [7] Fibroblast Growth Factor-21 Is a Promising Dietary Restriction Mimetic
    Mendelsohn, Andrew R.
    Larrick, James W.
    REJUVENATION RESEARCH, 2012, 15 (06) : 624 - 628
  • [8] Fibroblast growth factor-21 as a therapeutic agent for metabolic diseases
    Kharitonenkov, Alexei
    Shanafelt, Armen B.
    BIODRUGS, 2008, 22 (01) : 37 - 44
  • [9] Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases
    Alexei Kharitonenkov
    Armen B. Shanafelt
    BioDrugs, 2008, 22 : 37 - 44
  • [10] Acromegaly is associated with high fibroblast growth factor-21 levels
    Yurekli, B. S.
    Kutbay, N. O.
    Aksit, M.
    Suner, A.
    Simsir, I. Y.
    Seckiner, S.
    Kocabas, G. U.
    Bozkaya, G.
    Saygili, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (01) : 53 - 60